Sigifredo Pedraza-Sánchez Julia I Méndez-León Yolanda Gonzalez María Laura Ventura-Ayala María Teresa Herrera Jose Luis Lezana-Fernández Joseph A Bellanti Martha Torres
10.3389/fimmu.2018.02956
Front Immunol
2018 Dec 21;9:2956.
candida albicans nadph oxidase human immunoglobulin immunodeficiency mouthwash mucocutaneous candidiasis opsonization phagocytosis
CC BY
https://pubmed.ncbi.nlm.nih.gov/30627128/
Antifungal Agents / administration & dosage Candidiasis, Chronic Mucocutaneous / drug therapy Candidiasis, Oral / drug therapy Immunoglobulins, Intravenous / administration & dosage Mouthwashes / administration & dosage
Antifungal Agents / administration & dosage Candidiasis, Chronic Mucocutaneous / drug therapy Candidiasis, Oral / drug therapy Immunoglobulins, Intravenous / administration & dosage Mouthwashes / administration & dosage Case Reports Research Support, Non-U.S. Gov't Administration, Oral Candida albicans / drug effects Candida albicans / immunology Candida albicans / isolation & purification Candidiasis, Chronic Mucocutaneous / genetics Candidiasis, Chronic Mucocutaneous / immunology Candidiasis, Chronic Mucocutaneous / microbiology Candidiasis, Oral / genetics Candidiasis, Oral / immunology Candidiasis, Oral / microbiology Caspofungin / administration & dosage Child Drug Resistance, Fungal / drug effects Drug Resistance, Fungal / immunology Drug Therapy, Combination Female Humans Mutation Nystatin / administration & dosage Phagocytes / drug effects Phagocytes / immunology Treatment Outcome Antifungal Agents Immunoglobulins, Intravenous Mouthwashes Nystatin Caspofungin
PMC6309162
30627128
Oral Administration of Human Polyvalent IgG by Mouthwash as an Adjunctive Treatment of Chronic Oral Candidiasis
2018